Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6016551 | European Journal of Paediatric Neurology | 2016 | 40 Pages |
Abstract
Based on our results we can conclude that: 1. GPI-anchor biosynthesis disorders may represent a relatively frequent and overlooked metabolic defect; 2. The utility of GPI binding assessment as a screening test for this group of rare diseases requires further studies.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Aleksandra Jezela-Stanek, Elżbieta Ciara, Dorota Piekutowska-Abramczuk, Joanna Trubicka, Elżbieta Jurkiewicz, Dariusz Rokicki, Hanna Mierzewska, Justyna Spychalska, MaÅgorzata Uhrynowska, Marta Szwarc-Bronikowska, Piotr Buda, Abdul Rahim Said,